Form SC 13G/A Proto Labs Inc Filed by: VANGUARD GROUP INC

Go back to Form SC 13G/A Proto Labs Inc Filed by: VANGUARD GROUP INC

Benchmark Upgrades Proto Labs (PRLB) to Buy, '4Q22 Earnings, Forward Guidance Both Positive'

February 13, 2023 6:21 AM EST

Benchmark analyst Robert Wasserman upgraded Proto Labs (NYSE: PRLB) from Hold to Buy with a price target of $45.00.

THe analyst comments "Proto Labs reported better-than-expected financial results for their 4Q22, including revenues of $115.6 million, down 6.5% year-over-year, and nonGAAP earnings of $0.26 per share. Our estimates... More